MSCV-hspCas9-EF1α-GFP Two Vector Cas9 SmartNuclease™ Lentivector

When working with difficult-to-transfect-cells, use our lentiviral Cas9 SmartNuclease System. This vector drives Cas9 expression with MSCV and has a GFP marker.
  • Conduct genome editing and engineering in difficult-to-transfect cell lines
  • Drive Cas9 expression from the MSCV promoter, for high expression in hematopoietic and stem cells
  • Check transduction efficiencies with the GFP marker
  • Perform in vivo engineering of model organisms
  • Supports synthetic biology applications, gene- and cell-based therapy development, and genome-wide functional screening

Products

Catalog Number Description Size Price Quantity Add to Cart
CASLV125PA-1 Cas9 expression vector for the Two Vector SmartNuclease System (MSCV-hspCas9-EF1α-GFP Lentivector Plasmid) 10 µg $643
- +
CASLV125PA-KIT KIT: Cas9 expression vector for the Two Vector SmartNuclease System (MSCV-hspCas9-EF1α-GFP Lentivector Plasmid) plus LentiStarter Packaging Kit 1 Kit $1075
- +
CASLV125VA-1 Cas9 expression vector for the Two Vector SmartNuclease System (MSCV-hspCas9-EF1α-GFP Lentivector Pre-Packaged Lentiviral Particles (>10^6 IFUs)) 2 x 25 µL $643
- +

Overview

Overview

Genome editing in transfection-resistant cells with a GFP marker

When you want to create stable Cas9 editing cell lines and/or would like to edit the genome of a cell line that is resistant to transfection by plasmids, turn to one of SBI’s Cas9 SmartNuclease Lentivector Systems. Available as lentivector plasmids, ready-to-transduce pre-packaged pseudovirus, and in a package-your-own-lentivector kit with the lentivector plasmid and the LentiStarter 3.0 Packaging Kit, the MSCV-hspCas9-EF1α-GFP Two Vector Cas9 SmartNuclease™ Lentivector expresses human codon-optimized Cas9 wild-type nuclease from the strong MSCV promoter. The vector also includes a GFP marker expressed from the EF1α promoter to verify transduction efficiencies.

All pseudoviral particle preparations have been packaged to exacting QC standards and come with functional titer and in-house transduction data for each production lot of virus.

MSCV-hspCas9-EF1α-GFP Two Vector Cas9 SmartNuclease Lentivector
  • Conduct genome editing and engineering in difficult-to-transfect cell lines
  • Drive Cas9 expression from the MSCV promoter, for high expression in hematopoietic and stem cells
  • Check transduction efficiencies with the GFP marker
  • Perform in vivo engineering of model organisms
  • Supports synthetic biology applications, gene- and cell-based therapy development, and genome-wide functional screening

Why an HR targeting vector is a recommended

Even though gene knock-outs can result from DSBs caused by Cas9 alone, SBI recommends the use of HR targeting vectors (also called HR donor vectors) for more efficient and precise mutation. HR donors can supply elements for positive or negative selection ensuring easier identification of successful mutation events. In addition, HR donors can include up to 6-8 kb of open reading frame for gene knock-ins or tagging, and, when small mutations are included in either 5’ or 3’ homology arms, can make specific, targeted gene edits.

Not sure whether you need a CRISPR/Cas9 plasmid, purified protein, or mRNA?

Use this table to choose the CRISPR/Cas9 product that’s right for you:

For This Application
In these types of cells
Use These Products
MODIFYING ORGANISMS

  • Gene tagging

  • Transgenic organism generation

  • Model organism engineering

Embryos—to create transgenic animalsInjectable Cas9 mRNA & gRNA Synthesis Kits
Cas9 Protein
EGFP-labeled Cas9 Protein
Animals models—in vivo genome editingAAV-Cas9 Vectors  
Cas9 Protein
EGFP-labeled Cas9 Protein
MODIFYING CELL LINES

  • Stable KO, KI, and genome editing of
    somatic cells

  • Transgenic cell line generation

  • Cell-based disease models

Cells that are transfectableCas9 Plasmids
Cas9 Protein
EGFP-labeled Cas9 Protein
Difficult-to-transfect cell lines:

  • Primary cells

  • Hematopoietic cells

  • Stem cells

AAV-Cas9 Vectors 
Lenti Cas9 Systems
SCREENING

  • Genome-wide surveys

  • gRNA library screens

  • Functional screens

All cell types requiring stable Cas9 overexpressionLenti Cas9 Systems
AAVS1 Safe Harbor Site Cas9
Gene Knock-in System
Cas9 Protein
EGFP-labeled Cas9 Protein
PRE-CLINICAL APPLICATIONS
  • Off-target events are of highest concern
All cell types and applicationsCas9 Nickase, available in all delivery formats
Cas9 Protein
EGFP-labeled Cas9 Protein
SIMULTANEOUS ENGINEERING OF MULTIPLE MUTATIONSAll cell types and applicationsMultiplex gRNA cloning kit, compatible with all Cas9 delivery options

References

How It Works

How It Works

Genome engineering with CRISPR/Cas9

For general guidance on using CRISPR/Cas9 technology for genome engineering, take a look at our CRISPR/Cas9 tutorials as well as the following application notes:

CRISPR/Cas9 Gene Knock-Out Application Note (PDF) »
CRISPR/Cas9 Gene Editing Application Note (PDF) »
CRISPR/Cas9 Gene Tagging Application Note (PDF) »

CRISPR/Cas9 Basics

Through careful selection of the target sequence and design of a donor plasmid for homologous recombination, you can achieve efficient and highly targeted genomic modification with CRISPR/Cas9.

The system

A quick overview of the CRISPR/Cas9 System.

Cas9 protein—uses guide RNA (gRNA) to direct site-specific, double-strand DNA cleavage adjacent to a protospacer adapter motif (PAM) in the target DNA.

gRNA—RNA sequence that guides Cas9 to cleave a homologous region in the target genome. Efficient cleavage only where the gRNA homology is adjacent to a PAM.

PAM—protospacer adapter motif, NGG, is a target DNA sequence that spCas9 will cut upstream from if directed to by the gRNA.

The workflow at-a-glance

DESIGN: Select gRNA and HR donor plasmids. Choice of gRNA site and design of donor plasmid determines whether the homologous recombination event results in a knock-out, knock-in, edit, or tagging.

CONSTRUCT: Clone gRNA into all-in-one Cas9 vector. Clone 5’ and 3’ homology arms into HR donor plasmid. If creating a knock-in, clone desired gene into HR donor.

CO-TRANSFECT or CO-INJECT: Introduce Cas9, gRNA, and HR Donors into the target cells using co-transfection for plasmids, co-transduction for lentivirus, or co-injection for mRNAs.

SELECT/SCREEN: Select or screen for mutants and verify.

VALIDATE: Genotype or sequence putative mutants to verify single or biallelic conversion.

Supporting Data

Supporting Data

See Two Vector Cas9 SmartNuclease Lentivectors in action

MSCV-driven Cas9 and CMV-driven Two Vector Cas9 SmartNuclease Lentivectors efficiently deliver Cas9 to transduced cells for efficient genome editing.

Two-Vector Cas9-Lentiviruses efficiently knockout stable RFP reporter gene

Two-Vector Cas9-Lentiviruses efficiently knockout stable RFP reporter gene

Figure 1. Two Vector Cas9 Lentiviruses efficiently knockout stable RFP reporter gene. METHODS: Phase and fluorescent images of modified HEK293T cells stably expressing RFP and GFP (top panels), which have been co-infected (MOI = 3) with the MSCV-Cas9-T2A-Puro Two Vector Cas9 SmartNuclease Lentivector (Cat.# CASLV125VA-1) and a gRNA virus expressing a guide RNA targeting RFP (EF1α-Blasticidin-H1-RFP gRNA, Cat.# CASLV500PA-B; bottom panels). Images of cells were taken 11 days after placing the cells under selection, and show ablation of RFP expression in target cells infected with both the Cas9-expressing Lentivector and gRNA-expressing Lentivector (bottom panels).

Transduce Cancer Cell Lines with Cas9-LentivirusPhase images of Cas9 lentivirus transducing the cancer cell line MCF-7Immunostained images of Cas9 lentivirus transducing the cancer cell line MCF-7

Figure 2. Transduce Cancer Cell Lines with Cas9-Lentivirus. METHODS: (Top panels) Phase microscopy image of MCF-7 breast cancer cells infected with pseudoviral particles of CMV-hspCas9-T2A-Puro (Cat #CASLV100VA-1) and selected with Puromycin (1 µg/ml) for 10 days in culture, show distinct colony formation. (Bottom panels) Immunofluorescence staining of Cas9 protein expression in MCF-7 cell lines stably transduced with the CMV-hspCas9-T2A-Puro Two Vector Cas9 SmartNuclease Lentivector (Cat #CASLV100VA-1), show punctuate nuclear and perinuclear staining indicative of strong Cas9 protein expression in the nucleus.

FAQs

Resources

Citations

Products

Catalog Number Description Size Price Quantity Add to Cart
CASLV125PA-1 Cas9 expression vector for the Two Vector SmartNuclease System (MSCV-hspCas9-EF1α-GFP Lentivector Plasmid) 10 µg $643
- +
CASLV125PA-KIT KIT: Cas9 expression vector for the Two Vector SmartNuclease System (MSCV-hspCas9-EF1α-GFP Lentivector Plasmid) plus LentiStarter Packaging Kit 1 Kit $1075
- +
CASLV125VA-1 Cas9 expression vector for the Two Vector SmartNuclease System (MSCV-hspCas9-EF1α-GFP Lentivector Pre-Packaged Lentiviral Particles (>10^6 IFUs)) 2 x 25 µL $643
- +

Overview

Overview

Genome editing in transfection-resistant cells with a GFP marker

When you want to create stable Cas9 editing cell lines and/or would like to edit the genome of a cell line that is resistant to transfection by plasmids, turn to one of SBI’s Cas9 SmartNuclease Lentivector Systems. Available as lentivector plasmids, ready-to-transduce pre-packaged pseudovirus, and in a package-your-own-lentivector kit with the lentivector plasmid and the LentiStarter 3.0 Packaging Kit, the MSCV-hspCas9-EF1α-GFP Two Vector Cas9 SmartNuclease™ Lentivector expresses human codon-optimized Cas9 wild-type nuclease from the strong MSCV promoter. The vector also includes a GFP marker expressed from the EF1α promoter to verify transduction efficiencies.

All pseudoviral particle preparations have been packaged to exacting QC standards and come with functional titer and in-house transduction data for each production lot of virus.

MSCV-hspCas9-EF1α-GFP Two Vector Cas9 SmartNuclease Lentivector
  • Conduct genome editing and engineering in difficult-to-transfect cell lines
  • Drive Cas9 expression from the MSCV promoter, for high expression in hematopoietic and stem cells
  • Check transduction efficiencies with the GFP marker
  • Perform in vivo engineering of model organisms
  • Supports synthetic biology applications, gene- and cell-based therapy development, and genome-wide functional screening

Why an HR targeting vector is a recommended

Even though gene knock-outs can result from DSBs caused by Cas9 alone, SBI recommends the use of HR targeting vectors (also called HR donor vectors) for more efficient and precise mutation. HR donors can supply elements for positive or negative selection ensuring easier identification of successful mutation events. In addition, HR donors can include up to 6-8 kb of open reading frame for gene knock-ins or tagging, and, when small mutations are included in either 5’ or 3’ homology arms, can make specific, targeted gene edits.

Not sure whether you need a CRISPR/Cas9 plasmid, purified protein, or mRNA?

Use this table to choose the CRISPR/Cas9 product that’s right for you:

For This Application
In these types of cells
Use These Products
MODIFYING ORGANISMS

  • Gene tagging

  • Transgenic organism generation

  • Model organism engineering

Embryos—to create transgenic animalsInjectable Cas9 mRNA & gRNA Synthesis Kits
Cas9 Protein
EGFP-labeled Cas9 Protein
Animals models—in vivo genome editingAAV-Cas9 Vectors  
Cas9 Protein
EGFP-labeled Cas9 Protein
MODIFYING CELL LINES

  • Stable KO, KI, and genome editing of
    somatic cells

  • Transgenic cell line generation

  • Cell-based disease models

Cells that are transfectableCas9 Plasmids
Cas9 Protein
EGFP-labeled Cas9 Protein
Difficult-to-transfect cell lines:

  • Primary cells

  • Hematopoietic cells

  • Stem cells

AAV-Cas9 Vectors 
Lenti Cas9 Systems
SCREENING

  • Genome-wide surveys

  • gRNA library screens

  • Functional screens

All cell types requiring stable Cas9 overexpressionLenti Cas9 Systems
AAVS1 Safe Harbor Site Cas9
Gene Knock-in System
Cas9 Protein
EGFP-labeled Cas9 Protein
PRE-CLINICAL APPLICATIONS
  • Off-target events are of highest concern
All cell types and applicationsCas9 Nickase, available in all delivery formats
Cas9 Protein
EGFP-labeled Cas9 Protein
SIMULTANEOUS ENGINEERING OF MULTIPLE MUTATIONSAll cell types and applicationsMultiplex gRNA cloning kit, compatible with all Cas9 delivery options

References

How It Works

How It Works

Genome engineering with CRISPR/Cas9

For general guidance on using CRISPR/Cas9 technology for genome engineering, take a look at our CRISPR/Cas9 tutorials as well as the following application notes:

CRISPR/Cas9 Gene Knock-Out Application Note (PDF) »
CRISPR/Cas9 Gene Editing Application Note (PDF) »
CRISPR/Cas9 Gene Tagging Application Note (PDF) »

CRISPR/Cas9 Basics

Through careful selection of the target sequence and design of a donor plasmid for homologous recombination, you can achieve efficient and highly targeted genomic modification with CRISPR/Cas9.

The system

A quick overview of the CRISPR/Cas9 System.

Cas9 protein—uses guide RNA (gRNA) to direct site-specific, double-strand DNA cleavage adjacent to a protospacer adapter motif (PAM) in the target DNA.

gRNA—RNA sequence that guides Cas9 to cleave a homologous region in the target genome. Efficient cleavage only where the gRNA homology is adjacent to a PAM.

PAM—protospacer adapter motif, NGG, is a target DNA sequence that spCas9 will cut upstream from if directed to by the gRNA.

The workflow at-a-glance

DESIGN: Select gRNA and HR donor plasmids. Choice of gRNA site and design of donor plasmid determines whether the homologous recombination event results in a knock-out, knock-in, edit, or tagging.

CONSTRUCT: Clone gRNA into all-in-one Cas9 vector. Clone 5’ and 3’ homology arms into HR donor plasmid. If creating a knock-in, clone desired gene into HR donor.

CO-TRANSFECT or CO-INJECT: Introduce Cas9, gRNA, and HR Donors into the target cells using co-transfection for plasmids, co-transduction for lentivirus, or co-injection for mRNAs.

SELECT/SCREEN: Select or screen for mutants and verify.

VALIDATE: Genotype or sequence putative mutants to verify single or biallelic conversion.

Supporting Data

Supporting Data

See Two Vector Cas9 SmartNuclease Lentivectors in action

MSCV-driven Cas9 and CMV-driven Two Vector Cas9 SmartNuclease Lentivectors efficiently deliver Cas9 to transduced cells for efficient genome editing.

Two-Vector Cas9-Lentiviruses efficiently knockout stable RFP reporter gene

Two-Vector Cas9-Lentiviruses efficiently knockout stable RFP reporter gene

Figure 1. Two Vector Cas9 Lentiviruses efficiently knockout stable RFP reporter gene. METHODS: Phase and fluorescent images of modified HEK293T cells stably expressing RFP and GFP (top panels), which have been co-infected (MOI = 3) with the MSCV-Cas9-T2A-Puro Two Vector Cas9 SmartNuclease Lentivector (Cat.# CASLV125VA-1) and a gRNA virus expressing a guide RNA targeting RFP (EF1α-Blasticidin-H1-RFP gRNA, Cat.# CASLV500PA-B; bottom panels). Images of cells were taken 11 days after placing the cells under selection, and show ablation of RFP expression in target cells infected with both the Cas9-expressing Lentivector and gRNA-expressing Lentivector (bottom panels).

Transduce Cancer Cell Lines with Cas9-LentivirusPhase images of Cas9 lentivirus transducing the cancer cell line MCF-7Immunostained images of Cas9 lentivirus transducing the cancer cell line MCF-7

Figure 2. Transduce Cancer Cell Lines with Cas9-Lentivirus. METHODS: (Top panels) Phase microscopy image of MCF-7 breast cancer cells infected with pseudoviral particles of CMV-hspCas9-T2A-Puro (Cat #CASLV100VA-1) and selected with Puromycin (1 µg/ml) for 10 days in culture, show distinct colony formation. (Bottom panels) Immunofluorescence staining of Cas9 protein expression in MCF-7 cell lines stably transduced with the CMV-hspCas9-T2A-Puro Two Vector Cas9 SmartNuclease Lentivector (Cat #CASLV100VA-1), show punctuate nuclear and perinuclear staining indicative of strong Cas9 protein expression in the nucleus.

FAQs

Citations